VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $279,000 | +34.8% | 11,980 | -7.9% | 0.00% | – |
| Q1 2018 | $207,000 | -18.5% | 13,010 | +6.6% | 0.00% | – |
| Q4 2017 | $254,000 | -19.6% | 12,208 | -44.7% | 0.00% | – |
| Q3 2017 | $316,000 | -50.5% | 22,060 | -40.2% | 0.00% | – |
| Q2 2017 | $639,000 | +31.2% | 36,916 | -16.4% | 0.00% | – |
| Q1 2017 | $487,000 | -0.4% | 44,149 | +31.3% | 0.00% | – |
| Q4 2016 | $489,000 | +12.4% | 33,615 | +87.5% | 0.00% | – |
| Q3 2016 | $435,000 | -45.6% | 17,929 | -55.1% | 0.00% | – |
| Q2 2016 | $800,000 | -14.2% | 39,896 | +3.8% | 0.00% | -100.0% |
| Q1 2016 | $932,000 | -71.9% | 38,418 | +17.7% | 0.00% | -50.0% |
| Q4 2015 | $3,314,000 | -89.5% | 32,636 | -82.2% | 0.00% | -90.0% |
| Q3 2015 | $31,576,000 | -76.4% | 183,085 | -69.6% | 0.02% | -73.7% |
| Q2 2015 | $133,827,000 | +116.6% | 602,324 | +93.6% | 0.08% | +117.1% |
| Q1 2015 | $61,780,000 | +2472.0% | 311,080 | +1753.3% | 0.04% | +3400.0% |
| Q4 2014 | $2,402,000 | +26.8% | 16,785 | +16.2% | 0.00% | 0.0% |
| Q3 2014 | $1,895,000 | -65.1% | 14,440 | -66.4% | 0.00% | -66.7% |
| Q2 2014 | $5,428,000 | +143.8% | 43,036 | +154.5% | 0.00% | +200.0% |
| Q1 2014 | $2,226,000 | -84.2% | 16,908 | -85.9% | 0.00% | -88.9% |
| Q4 2013 | $14,087,000 | -9.8% | 119,993 | -19.9% | 0.01% | -10.0% |
| Q3 2013 | $15,626,000 | +3.6% | 149,754 | -14.5% | 0.01% | 0.0% |
| Q2 2013 | $15,078,000 | – | 175,159 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |